| For: | Li B. Microglial metabolic reprogramming: Aucubin inhibits aldose reductase to reverse diabetic neuropathic pain. World J Diabetes 2025; 16(8): 110285 [PMID: 40837338 DOI: 10.4239/wjd.v16.i8.110285] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i8/110285.htm |
| Number | Citing Articles |
| 1 |
Nurul Husna Abd Razak, Ubashini Vijakumaran, Izyan Mohd Idris, Jalilah Idris, Nur Hidayah Hassan, Fazlin Zaini, Noorzaid Muhamad, Muhammad Fauzi Daud. Hyperglycemia Modulates mTOR Signaling and Myelin Protein Expression in Schwann Cells. International Journal of Molecular Sciences 2025; 26(19) doi: 10.3390/ijms26199724
|
| 2 |
Mahmoud A.M. Arafat, Mostafa K. Mohammad, Kareem A. Attallah, Ahmed M. El-Dessouki, Samar S. Khalaf, Sally A. Fahim, Riham A. El-Shiekh, Reham Hassan Mekky, Hazim O. Khalifa. Aucubin as a multifunctional iridoid glycoside: Molecular pharmacology and therapeutic mechanisms supporting its potential as a drug discovery scaffold. European Journal of Pharmacology 2026; 1033 doi: 10.1016/j.ejphar.2026.179254
|
| 3 |
Yang Niu, Jiayu Han, Tao Song, Xueshu Tao. Targeting endoplasmic reticulum stress: a novel therapeutic strategy for neuropathic pain. Frontiers in Pain Research 2026; 7 doi: 10.3389/fpain.2026.1761647
|